NBVM GP LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-09 4:20 pm Purchase |
2023-05-31 | 13D | Lyra Therapeutics, Inc. LYRA |
NBVM GP LLC | 120,629 12.200% |
36,253 (+42.97%) |
Filing |
| 2022-04-22 4:20 pm Purchase |
2022-04-12 | 13D | Lyra Therapeutics, Inc. LYRA |
NBVM GP LLC | 84,376 13.200% |
50,097 (+146.15%) |
Filing |